Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe ...

ICER's evaluation of Vertex Pharmaceuticals' non-opioid pain drug, Journavx, finds cost-effectiveness related to potential ...

Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $512.52, indicating a +0.06% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 1. ...

In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.

Tool for decrypting and extracting RPG Maker XP, VX and VX Ace encrypted archives and MV and MZ encrypted files. Open-source cross-platform player for (some) RPG Maker XP / VX / VX Ace games. A very ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

“She had private health insurance with Laya Healthcare under a plan called Essential Connect Family which is coming in at a renewal price of €2,200,” Suzanne says. “I know that all health ...

The Ugreen PowerRoam 2200 is a portable power station that supports AC, car, and solar charging, and can be expanded by adding up to five extra battery packs. If you need power for a construction ...

Journavx works differently than other available medications, and its developer, the biotechnology juggernaut Vertex Pharmaceuticals, has positioned it as an important, non-opioid option for pain ...

A 20-80% charge for the drone takes only 30 minutes during driving. The drone system will be available for ¥16,000 ($2,200) on various models. Chinese automaker BYD has just released a new ...